January 5, 2026
Tiger BioSciences Announces Launch of New Dermatology Division, Expanding Access to Advanced Wound Care and Aesthetic Solutions
CONSHOHOCKEN, Pa., Jan. 5, 2026 /PRNewswire/ -- Tiger BioSciences officially launched its Dermatology Division, expanding the company's offerings in wound care and aesthetic solutions. The new division provides dermatologists with access to placental-derived wound care products, HealPack surgical dressings, and cosmetic offerings.
The division operates through a dedicated distribution channel with specialized support for dermatology practices.
"Dermatologists are uniquely positioned at the intersection of wound and aesthetic treatments," stated Scott Madden, Co-CEO of Tiger BioSciences.
Oliver Burckhardt, Co-CEO, emphasized the company's focus: "Our goal is to provide dermatologists with best-in-class aesthetic innovations backed by scientific and clinical data."
The launch combines Tiger BioSciences' existing wound care technologies with aesthetic solutions, creating a comprehensive offering for dermatologists managing both clinical wounds and cosmetic treatments. The division includes expanded field support and access to scientific resources.
About Tiger BioSciences
Tiger BioSciences, headquartered in Conshohocken, PA, specializes in cellular and tissue technology, processing innovations, and aesthetic devices across multiple medical applications.
SOURCE Tiger BioSciences
More from the Press Room
April 1, 2026Tiger BioSciences Announces the Launch of carePAC® Pre-Configured Wound Care Convenience Kits Designed to Simplify At-Home Wound Management
Tiger BioSciences launches carePAC®, a line of pre-configured wound care convenience kits designed to simplify dressing changes and improve access to essential wound care supplies for patients managing wounds at home.
Read more
December 30, 2025Tiger BioSciences Spotlights Major Clinical and Scientific Milestones Following Significant 2025 Research Investment
Tiger BioSciences announces significant clinical and scientific accomplishments from expanded research investments throughout 2025, including five peer-reviewed studies and new randomized controlled trials.
Read more
December 8, 2025Tiger BioSciences Highlights Study on Advanced Placental CAMP Technologies
A pivotal study published in the International Journal of Molecular Sciences evaluates placental-derived allograft technologies for wound care applications through improved biological preservation methods.
Read more